About us

Leading the way in physician-led clinical trials

Yanuvia is the unique integrated research organization created out of one physician’s desire to elevate clinical trial procedures. The result: We provide significant advantages for both medical practices and trial sponsors — faster start up, streamlined processes, and the highest quality every step of the way.

For years, clinical research trials were all conducted in much the same way: a time-consuming, challenging procedure that made sponsors anxious, burdened patients, and held little attraction for physician involvement.

But at Yanuvia, we’ve changed all that — for the better. Our unique focus on community physician-led clinical trials has transformed the landscape. Sponsors can focus on analyzing the data and bringing their products to market sooner, while physicians can further advance patient care while realizing ancillary revenue.

We invite you to experience a more cost-effective, more productive and less stressful clinical trial experience.

Meet our team

Hillel D. Cohen, M.D.​

Chief Executive Officer and Founder

A Board Certified gastroenterologist with 14 years of private practice experience, Hillel founded Yanuvia in 2020. He received his medical degree from Rutgers University, where he was named a member of the Alpha Omega Alpha honors society.

His practice years earned him high praise from patients and peers alike; Hillel has received the Castle Connolly Top Doctors award on multiple occasions, and has twice been named to the “Outstanding Physicians Of The World.”

Lianne K. Cavell, M.D.

Chief Medical Officer

Dr. Lianne Cavell is a board-certified gastroenterologist with 11 years of experience in private practice. She earned her medical degree from Albert Einstein College of medicine where she was inducted into the prestigious Alpha Omega Alpha Honor Society. Dr. Cavell completed her residency at New York Presbyterian/Weill Cornell Medical Center and advanced her training with a fellowship at Memorial Sloan Kettering Cancer Center specializing in gastroenterology with a strong focus on oncology.

Randy Schwartz

Chief Operating Officer and Chief Financial Officer

A results-driven healthcare management professional with almost 30 years of diverse leadership experience in both large-scale private practice and hospital settings.  Responsibilities included oversight of daily operations, finance and strategic growth initiatives.

Randy received his degree in Business Administration from Emory University – Goizueta Business School. 

Sheik J. Khan, MBBS, MPH, PhD.

Chief Compliance Officer

A distinguished medical scientist, Sheik has extensive experience with pre-clinical and clinical research. He received his MBBS overseas, his postgraduate training at the University of London, followed by his doctorate in Biochemistry & Molecular Biology from the University of Miami.

Sheik has managed several public health regulatory programs and holds a second master’s degree in public health from Florida International University. In addition, he holds a green belt in Lean Six Sigma, and an executive certificate in Project Management.

Erika Vento-Gaudens

Vice President Of Clinical Operations

Erika is a tenured clinical research executive with nearly 30 years of experience. With a foundation in Kansas City’s Marion Laboratories, she has been an influential leader at both pharma and CRO corporations, as well as small start-up pharma companies and CROs. Her career has been driven by the pursuit of improving patient lives through clinical research alongside her fellow healthcare professionals. In her spare time, she enjoys traveling, learning new languages, spending time with family, and running.

Stephen Caron

Vice President of Clinical Operations Therapeutics

Stephen is the Vice President of Clinical Operations at Yanuvia, where he is responsible for building and scaling the operational infrastructure to support the company’s expanding clinical research network. He brings more than 25 years of experience in the clinical research industry, with a focus on global trial execution, site activation, and operational strategy across Phase I–IV studies.

 

Stephen has held leadership roles across contract research organizations (CROs) and research networks, where he has led the operational delivery of multi-country clinical trials and developed scalable processes to support efficient, high-quality execution. He has also worked closely with community-based site networks, with a focus on expanding access to clinical research beyond traditional academic settings.

David Riddle

Vice President, Technology

A distinguished global technology executive, David brings extensive experience in life sciences and contract research. He has led global technology operations, digital transformation, and cybersecurity initiatives across private equity- and venture capital-backed organizations. He earned a bachelor’s degree from Harvard University.
 
He specializes in building scalable, resilient, and compliant technology foundations that enable scientific, operational, and commercial outcomes across enterprise and product domains. He has partnered closely with leadership teams, boards, and investors to drive value creation, support M&A integration, and guide organizations through complex change in regulated environments.
 
David has helped organizations achieve strong growth and enterprise value, and he has supported award-winning work recognized by the Fierce Life Sciences Awards, the R&D 100 Awards, and the Edison Awards.

Natasha Rodriguez, NCMA

Director Of Clinical Research

With more than a decade of clinical research experience, Natasha has a keen understanding of conducting and managing clinical trials. She has been a clinical research coordinator, associate and director for studies in gastroenterology, oncology, cardiology, women’s health and endocrinology.